PTC Therapeutics, Inc.PTCTNASDAQ
LOADING
|||
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q3 2025 | 17.96% |
| Q2 2025 | -84.79% |
| Q1 2025 | 451.71% |
| Q4 2024 | 8.33% |
| Q3 2024 | 5.40% |
| Q2 2024 | -11.14% |
| Q1 2024 | -31.57% |
| Q4 2023 | 56.20% |
| Q3 2023 | -8.06% |
| Q2 2023 | -2.98% |
| Q1 2023 | 31.64% |
| Q4 2022 | -22.90% |
| Q3 2022 | 31.17% |
| Q2 2022 | 11.29% |
| Q1 2022 | -9.98% |
| Q4 2021 | 19.09% |
| Q3 2021 | 18.91% |
| Q2 2021 | -1.07% |
| Q1 2021 | -0.78% |
| Q4 2020 | 0.39% |
| Q3 2020 | 57.37% |
| Q2 2020 | 10.23% |
| Q1 2020 | -29.24% |
| Q4 2019 | 35.07% |
| Q3 2019 | -16.49% |
| Q2 2019 | 59.61% |
| Q1 2019 | -37.94% |
| Q4 2018 | 61.11% |
| Q3 2018 | -22.04% |
| Q2 2018 | 22.62% |
| Q1 2018 | -28.15% |
| Q4 2017 | 86.44% |
| Q3 2017 | -12.74% |
| Q2 2017 | 80.67% |
| Q1 2017 | 5.38% |
| Q4 2016 | 9.59% |
| Q3 2016 | 47.04% |
| Q2 2016 | -17.26% |
| Q1 2016 | 48.38% |
| Q4 2015 | 30.28% |